NCT03230162: Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment
- State
- State not given
- Phase
- Phase 3
- People
- 100 planned
- Started
- 1 Jun 2017
- Primary completion
- 1 May 2018
- Arms
- low molecular weight heparin
- Results
- None posted
- 1 Jun 2017: Trial started
- 26 Jul 2017: Trial registered